Skip to content

KC PHARMA

Active Private limited companyfounded 2003active for 23 yearsLeeuwerikheide 86, 2400 MolKBO/BCE: BE 0479.334.705

Timeline

37 events since 2003

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · 3 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0479334705
2025
Annual accounts 2024 filed PDFabbreviated format · on the deadline day
2024
Annual accounts 2023 filed PDFabbreviated format · 26 days before the deadline
2023
changes role from manager to directorGeneral meeting of 01-12-20235 points ▸
  • The capital is divided into 1,200 shares
  • General meeting of 01-12-2023
  • resigns as manager
  • appointed as director, not named in the articles
  • The registered office is at Leeuwerikheide 86, 2400 Mol
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFabbreviated format · 3 days before the deadline
2022
Annual accounts 2021 filed PDFabbreviated format · 6 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 2 days before the deadline
2020
Liquidity times 8 current ratio 4.02 The current ratio rises from 0.50 to 4.02. Short-term debt falls from €519,181 to €190,347.
Annual accounts 2019 filed PDFabbreviated format · 2 days before the deadline
2019
Annual accounts 2018 filed PDFabbreviated format · 8 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 12 days before the deadline
Capital decrease of €420,000 to €36,500The capital fell from €456,500 to €36,5002 points ▸
  • The capital was reduced by €420,000
  • The capital is €36,500, divided into 1,200 shares
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2017
Annual accounts 2016 filed PDFabbreviated format · 23 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 30 days before the deadline
Registered office moved within MolThe registered office moved from Ginderbuiten 119, 2400 Mol to Leeuwerikheide 86, 2400 Mol1 point ▸
2015
Annual accounts 2014 filed PDFabbreviated format · 3 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 1 day late
2013
Liquidity more than 12 times current ratio 1.20 The current ratio rises from 0.09 to 1.20. Short-term debt falls from €261,845 to €240,958.
Capital increase of €420,000 to €456,500The capital rose from €36,500 to €456,500 · Contribution by 5 points ▸
  • The capital was increased by €420,000
  • Capital contribution, €420,000
  • The capital is €456,500
  • Power of attorney granted to
  • Article 5 of the articles of association amended
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2012 filed PDFabbreviated format · 33 days before the deadline
2012
Demerger: COECKELBERGHS EN CROUX splits off to Founding capital of €83,500 · Company renamed from COECKELBERGHS EN CROUX to KC PHARMA · Capital decrease of €83,500 to €36,500 · The capital fell from €120,000 to €36,500 · General meeting of 06-08-201210 points ▸
  • General meeting of 06-08-2012
  • The capital was reduced by €83,500
  • The operation takes effect in the accounts on 01-01-2012
  • The founding capital is €83,500, divided into 100 shares
  • holds 100 shares
  • The capital is €83,500, divided into 100 shares
  • appointed as manager
  • Name change, KC PHARMA
  • The capital is €36,500, divided into 1,200 shares
  • Power of attorney granted to
  • The deed holds 20 more points.

Open the deed in the Belgian Official Gazette

Demerger: COECKELBERGHS EN CROUX splits off to Company renamed from COECKELBERGHS EN CROUX to KC PHARMA · Capital decrease of €83,500 to €36,500 · The capital fell from €120,000 to €36,5008 points ▸
  • The capital was reduced by €83,500
  • The operation takes effect in the accounts on 01-01-2012
  • Name change, KC PHARMA
  • The capital is €36,500, divided into 1,200 shares
  • Power of attorney granted to
  • The founding capital is €83,500, divided into 100 shares
  • holds 100 shares
  • appointed as manager
  • The deed holds 14 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2011 filed PDFabbreviated format · 28 days before the deadline
Demerger proposal: COECKELBERGHS EN CROUX splits off to 1 point ▸
  • The operation takes effect in the accounts on 01-01-2012
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

2011
Annual accounts 2010 filed PDFabbreviated format · 24 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 9 days before the deadline
2009
Highest result from 2006 to 2025 net €945,370 ▲1,299% The net result of €945,370 is the highest of those years.
Equity above €500,000 equity €564,872 ▲76.8% With a profit in every financial year since 2006, equity grows to €564,872.
Annual accounts 2008 filed PDFabbreviated format · 1 day before the deadline
2008
Annual accounts 2007 filed PDFabbreviated format · 3 days before the deadline
2007
Annual accounts 2006 filed PDFabbreviated format · on the deadline day
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
First establishment Leeuwerikheide 86, Mol
Incorporation PDFpublished on 24-01-2003

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 16 January 2003, KC PHARMA was incorporated.1 A capital increase in 2013 brought the capital to €456,500. After a decrease in 2018 the capital stands at €36,500.2 In 2016 the registered office moved within Mol.3 Total assets went from €1.3m in 2018 to €873,296 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 30-12-2013
  3. 3Belgian Official Gazette, 27-01-2016
  4. 4National Bank, annual accounts 2018 and 2025

Next steps